NCT01805895View on ClinicalTrials.gov

A Pilot Study of Minocycline in Intracerebral Hemorrhage Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Intracerebral Hemorrhage
Interventions
DRUG

Minocycline

This arm will receive a total of 5 doses of minocycline. Dose 1 will be 400mg IV within 12-hours of onset of symptoms. Dose 2 will be 400mg oral, given daily on days 2-5 . Each dose is 24 hours apart.

Trial Locations (1)

30912

Georgia Health Sciences University, Augusta

All Listed Sponsors
collaborator

American Heart Association

OTHER

lead

Augusta University

OTHER

NCT01805895 - A Pilot Study of Minocycline in Intracerebral Hemorrhage Patients | Biotech Hunter | Biotech Hunter